LV10953A - Substituted benzimidazoles for use in the manufacture of a pharmaceutical composition - Google Patents
Substituted benzimidazoles for use in the manufacture of a pharmaceutical compositionInfo
- Publication number
- LV10953A LV10953A LV931045A LV931045A LV10953A LV 10953 A LV10953 A LV 10953A LV 931045 A LV931045 A LV 931045A LV 931045 A LV931045 A LV 931045A LV 10953 A LV10953 A LV 10953A
- Authority
- LV
- Latvia
- Prior art keywords
- manufacture
- pharmaceutical composition
- substituted benzimidazoles
- benzimidazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002206A SE9002206D0 (en) | 1990-06-20 | 1990-06-20 | NEW COMPOUNDS |
PCT/SE1991/000415 WO1991019711A1 (en) | 1990-06-20 | 1991-06-11 | Substituted benzimidazoles, process for their preparation and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
LV10953A true LV10953A (en) | 1995-12-20 |
Family
ID=20379831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LV931045A LV10953A (en) | 1990-06-20 | 1993-08-27 | Substituted benzimidazoles for use in the manufacture of a pharmaceutical composition |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0535081A1 (en) |
JP (1) | JPH05507713A (en) |
CN (1) | CN1058212A (en) |
AP (1) | AP215A (en) |
AU (1) | AU649453B2 (en) |
BG (1) | BG97200A (en) |
CA (1) | CA2083714A1 (en) |
CZ (1) | CZ279772B6 (en) |
FI (1) | FI925766A (en) |
HU (1) | HUT62881A (en) |
IE (1) | IE912025A1 (en) |
IL (1) | IL98470A0 (en) |
IS (1) | IS3721A7 (en) |
LT (2) | LT3952B (en) |
LV (1) | LV10953A (en) |
MA (1) | MA22199A1 (en) |
NO (1) | NO924775L (en) |
NZ (1) | NZ238546A (en) |
OA (1) | OA09682A (en) |
PT (1) | PT98035A (en) |
RO (1) | RO110493B1 (en) |
SE (1) | SE9002206D0 (en) |
TN (1) | TNSN91049A1 (en) |
TW (1) | TW216418B (en) |
WO (1) | WO1991019711A1 (en) |
YU (1) | YU104191A (en) |
ZA (2) | ZA914296B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002043D0 (en) * | 1990-06-07 | 1990-06-07 | Astra Ab | IMPROVED METHOD FOR SYNTHESIS |
SE9103776D0 (en) * | 1991-12-19 | 1991-12-19 | Astra Ab | NEW COMPOUNDS |
IS4232A (en) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Substituted benzimidazole, its methods of manufacture and pharmacological use |
SE9500422D0 (en) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (en) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
SE9600070D0 (en) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
EP1257269B1 (en) | 2000-02-24 | 2004-11-03 | Kopran Research Laboratories Limited | Orally administrable acid stable anti-ulcer benzimidazole derivatives |
SE0101379D0 (en) | 2001-04-18 | 2001-04-18 | Diabact Ab | Composition that inhibits gastric acid secretion |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
DE60325709D1 (en) | 2002-04-09 | 2009-02-26 | Flamel Tech Sa | ORAL AQUEOUS SUSPENSION CONTAINING MICRO CAPSULES FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES |
SE0203065D0 (en) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
US8246986B2 (en) | 2003-09-26 | 2012-08-21 | Alza Corporation | Drug coating providing high drug loading |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20070015782A1 (en) * | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
WO2007122686A1 (en) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | Benzimidazole compounds |
JP5474541B2 (en) | 2006-07-25 | 2014-04-16 | ベクタ・リミテッド | Compositions and methods for inhibiting gastric acid secretion using PPI in combination with small dicarboxylic acid derivatives |
WO2008047681A1 (en) * | 2006-10-13 | 2008-04-24 | Eisai R & D Management Co., Ltd. | Benzimidazole compound having gastric acid secretion inhibitory activity |
CN102209529A (en) | 2008-09-09 | 2011-10-05 | 阿斯利康(瑞典)有限公司 | Method for delivering a pharmaceutical composition to patient in need thereof |
JP2012531409A (en) | 2009-06-25 | 2012-12-10 | アストラゼネカ・アクチエボラーグ | Methods for treating patients at risk of developing NSAID-related ulcers |
WO2011080501A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
EA028049B1 (en) | 2011-12-28 | 2017-10-31 | Поузен Инк. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
IL307576B1 (en) * | 2016-09-14 | 2025-02-01 | Yufeng Jane Tseng | Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (en) | 1974-02-18 | 1981-07-06 | Haessle Ab | ANALOGY PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH Gastric Acid Secretion Inhibitory Effects |
SE416649B (en) | 1974-05-16 | 1981-01-26 | Haessle Ab | PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion |
IN148930B (en) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (en) | 1978-04-14 | 1979-10-15 | Haessle Ab | Gastric acid secretion |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
CH644116A5 (en) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | IMIDAZOLE DERIVATIVES. |
SE8300736D0 (en) | 1983-02-11 | 1983-02-11 | Haessle Ab | NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS |
SE8301182D0 (en) | 1983-03-04 | 1983-03-04 | Haessle Ab | NOVEL COMPOUNDS |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
SE8505112D0 (en) * | 1985-10-29 | 1985-10-29 | Haessle Ab | NOVEL PHARMACOLOGICAL COMPOUNDS |
NZ222495A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
DE3722810A1 (en) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF |
AU2621888A (en) * | 1987-10-30 | 1989-05-23 | Aktiebolaget Hassle | Omeprazole for treatment of diseases related to bone loss |
ZA889194B (en) * | 1987-12-11 | 1989-08-30 | Byk Gulden Lomberg Chemisch Fa | Novel benzimidazole derivatives |
WO1989011479A1 (en) * | 1988-05-25 | 1989-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
-
1990
- 1990-06-20 SE SE9002206A patent/SE9002206D0/en unknown
-
1991
- 1991-06-05 ZA ZA914296A patent/ZA914296B/en unknown
- 1991-06-05 ZA ZA914297A patent/ZA914297B/en unknown
- 1991-06-11 JP JP91511435A patent/JPH05507713A/en active Pending
- 1991-06-11 WO PCT/SE1991/000415 patent/WO1991019711A1/en not_active Application Discontinuation
- 1991-06-11 CA CA002083714A patent/CA2083714A1/en not_active Abandoned
- 1991-06-11 RO RO92-01581A patent/RO110493B1/en unknown
- 1991-06-11 HU HU924033A patent/HUT62881A/en unknown
- 1991-06-11 EP EP91911659A patent/EP0535081A1/en not_active Withdrawn
- 1991-06-11 AU AU80097/91A patent/AU649453B2/en not_active Ceased
- 1991-06-12 YU YU104191A patent/YU104191A/en unknown
- 1991-06-12 TW TW080104582A patent/TW216418B/zh active
- 1991-06-12 IL IL98470A patent/IL98470A0/en unknown
- 1991-06-14 NZ NZ238546A patent/NZ238546A/en unknown
- 1991-06-14 IE IE202591A patent/IE912025A1/en unknown
- 1991-06-18 MA MA22462A patent/MA22199A1/en unknown
- 1991-06-19 TN TNTNSN91049A patent/TNSN91049A1/en unknown
- 1991-06-19 PT PT98035A patent/PT98035A/en not_active Application Discontinuation
- 1991-06-19 AP APAP/P/1991/000285A patent/AP215A/en active
- 1991-06-20 CN CN91105024A patent/CN1058212A/en active Pending
- 1991-06-20 IS IS3721A patent/IS3721A7/en unknown
- 1991-06-20 CZ CS911894A patent/CZ279772B6/en unknown
-
1992
- 1992-11-27 OA OA60306A patent/OA09682A/en unknown
- 1992-12-10 NO NO92924775A patent/NO924775L/en unknown
- 1992-12-18 BG BG097200A patent/BG97200A/en unknown
- 1992-12-18 FI FI925766A patent/FI925766A/en not_active Application Discontinuation
-
1993
- 1993-08-27 LV LV931045A patent/LV10953A/en unknown
- 1993-12-30 LT LTIP1712A patent/LT3952B/en not_active IP Right Cessation
- 1993-12-30 LT LTIP1713A patent/LT3977B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CS189491A3 (en) | 1992-04-15 |
WO1991019711A1 (en) | 1991-12-26 |
CN1058212A (en) | 1992-01-29 |
AP9100285A0 (en) | 1991-07-31 |
RO110493B1 (en) | 1996-01-30 |
BG97200A (en) | 1993-12-24 |
FI925766A0 (en) | 1992-12-18 |
LTIP1713A (en) | 1995-08-25 |
TNSN91049A1 (en) | 1992-10-25 |
NO924775D0 (en) | 1992-12-10 |
NZ238546A (en) | 1994-03-25 |
AU8009791A (en) | 1992-01-07 |
ZA914297B (en) | 1992-03-25 |
TW216418B (en) | 1993-11-21 |
YU104191A (en) | 1994-01-20 |
JPH05507713A (en) | 1993-11-04 |
AP215A (en) | 1992-09-02 |
IL98470A0 (en) | 1992-07-15 |
OA09682A (en) | 1993-05-15 |
IS3721A7 (en) | 1991-12-21 |
IE912025A1 (en) | 1992-01-01 |
FI925766A (en) | 1992-12-18 |
PT98035A (en) | 1992-03-31 |
HUT62881A (en) | 1993-06-28 |
AU649453B2 (en) | 1994-05-26 |
ZA914296B (en) | 1992-03-25 |
MA22199A1 (en) | 1992-04-01 |
SE9002206D0 (en) | 1990-06-20 |
CA2083714A1 (en) | 1991-12-21 |
HU9204033D0 (en) | 1993-03-29 |
LTIP1712A (en) | 1995-08-25 |
LT3952B (en) | 1996-05-27 |
CZ279772B6 (en) | 1995-06-14 |
EP0535081A1 (en) | 1993-04-07 |
LT3977B (en) | 1996-06-25 |
NO924775L (en) | 1992-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10953A (en) | Substituted benzimidazoles for use in the manufacture of a pharmaceutical composition | |
DE122004000023I2 (en) | Pharmaceutical composition | |
DE10199066I1 (en) | Pharmaceutical composition | |
LV10082A (en) | Propensics Derivatives Composition and Composition for Anti-Insect and Ercu Antiquities | |
EE03108B1 (en) | Pharmaceutical composition | |
FI981777A0 (en) | Pharmaceutical composition | |
SE8801813L (en) | PHARMACEUTICAL COMPOSITION | |
KR880005932A (en) | Pharmaceutical composition for reducing neurotoxicity damage | |
DE3486441D1 (en) | 3-hydroxypyrid-4-one and pharmaceutical compositions | |
ITRM910061A0 (en) | CONCRETE COMPOSITIONS TO BE SPRAYED | |
BG91785A (en) | MEDICINAL FORM | |
BR8902338A (en) | ORAL COMPOSITION | |
MX158797A (en) | IMPROVEMENTS TO THE CLEANSING COMPOSITION AND DEODORANT FOR THE BODY | |
DK683987D0 (en) | TOPICAL PHARMACEUTICAL PREPARATION FOR USE IN THE FORM OF TAPE | |
MX9200622A (en) | PHARMACEUTICAL COMPOSITION | |
BR8903994A (en) | ORAL COMPOSITION | |
ITTO920303A0 (en) | "ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION" | |
DE4294862T1 (en) | Pharmaceutical composition | |
UA26064A1 (en) | PHARMACEUTICAL COMPOSITION | |
DK0511991T3 (en) | Pharmaceutical formulation | |
ATA133288A (en) | PHARMACEUTICAL COMPOSITION | |
IT8721981A0 (en) | ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION WITH LONG-LASTING EFFECT FOR TOPICAL USE | |
IT9020943A0 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON-STEROID ANTI-INFLAMMATORS | |
LV10952A (en) | Therapeutically active fluorosubstituted benzimidazoles for use in the manufacture of said therapeutically active fluoro-substituted benzimidazoles | |
FI920845A (en) | PHARMACEUTICAL COMPOSITION INNEHAOLLANDE INTERLEUKIN-2 |